RG7834
目录号: A21816
HBV 抑制剂
RG7834 (RO 7020322) 是一种高度选择性且可口服生物利用的 HBV 抑制剂,在 dHepaRG 细胞中对 HBV 抗原(包括 HBsAg 和 HBeAg)和 HBV DNA 有强效抑制作用,其 IC50 分别为 2.8、2.6 和 3.2 nM。
Discription | RG7834 (RO 7020322) is a highly selective and orally bioavailable HBV inhibitor, potently inhibits HBV antigens (both HBsAg and HBeAg) and HBV DNA, with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells. | |||||
---|---|---|---|---|---|---|
Cell Research |
|
目录号 | A21816 |
---|---|
分子式 | C22H27NO6 |
分子量 | 401.45 |
CAS号 | 2072057-17-9 |
SMILES | O=C(O)C1=CN2[C@@H](CC3=CC(OCCCOC)=C(C=C3C2=CC1=O)OC)C(C)C |
其他名称 | RO 7020322, RO-7020322, RO7020322; RG 7834, RG-7834 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2